cold chain

BioNTechs headquarters

Pharma

BioNTech targets oral mRNA vaccines with delivery tech deal

Working with Matinas, BioNTech will study the potential for a lipid nanocrystal platform to enable new, more stable vaccine formulations.

Nick Paul Taylor Apr 12, 2022 8:05am

child receiving rotavirus vaccine

Serum’s heat-stable rotavirus vaccine shines in phase 3

Mar 28, 2017 2:07pm